Author:
Takara Kohji,Fujita Megumi,Minegaki Tetsuya,Yamamoto Kazuhiro,Takahashi Minoru,Yokoyama Teruyoshi,Okumura Katsuhiko
Reference27 articles.
1. Platinum group antitumor chemistry: design and development of new anticancer drugs complementary to cisplatin;Abu-Surrah;Curr. Med. Chem.,2006
2. Cellular determinants of oxaliplatin sensitivity in colon cancer cell lines;Arnould;Eur. J. Cancer,2003
3. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors;Chou;Adv. Enzyme Regul.,1984
4. The ICBP Module 1 Working Group. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data;Coleman;Lancet,2011
5. Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line;Esaki;Cancer Res.,1992
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献